Question:

I was reviewing the archive and came across a Q&A related to modifier JW. That answer states that the modifier relates only to single-use vials—a vial of liquid medication intended for parenteral administration (injection or infusion) that is meant for use in a single patient for a single case, procedure or injection. This would seem to mean that the modifier would not apply to packages for non-liquid drugs. Is that correct?

Answer:

The JW modifier applies to single-dose vials, but it also applies to single-use packages for drugs and biologicals that would not be dispensed in liquid form. This is for something such as skin substitutes or other single-use products that are applied or implanted and not infused.

Facebook
Twitter
LinkedIn

CPT® copyright 2024 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.

Celebrate Lab Week with MedLearn! Sign up to win one year of our Laboratory All Access Pass! Click here to learn more →

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24